The COVID booster currently available is based on the JN.1 subvariant. Nimbus is a direct descendant of JN.1 – as is another ...

HealthDay News — There was an overall decrease in influenza vaccine uptake among U.S. adults from 2020 to 2024, according to a study published online July 16 in PLOS Global Public Health.

Study reveals primary cause of obesity — and it's not lack of exercise Moment CNN contributor’s young son crashes tense ...

A CDC advisory panel vote to recommend against use of seasonal influenza vaccines containing small amounts of thimerosal ...

While the new panel showed little conflict over the 2025-2026 seasonal flu vaccine recommendations, thimerosal fueled sharp reactions among members and outside observers.

Moderna’s new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major trial.

The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by private equity firm Nordic Capital.